ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
06/01/2021 - 04:05 PM
ANI Pharmaceuticals, Inc. (“ANI“ or the “Company“) (Nasdaq: ANIP) today announced log-in details for its 2021 Virtual Annual Meeting of Stockholders to be held on June 2, 2021, beginning at 10 a.m. Eastern Time.
Stockholders can attend the virtual annual meeting via the internet at www.virtualshareholdermeeting.com/ANIP2021 . Stockholders of record as of the close of business on April 26, 2021 will be eligible to vote their shares and submit questions electronically in advance of and during the virtual annual meeting by using the 16-digit control number included on their individual proxy card or on the voting instruction form accompanying the proxy materials to attend the annual meeting. Stockholders may begin to log in to the meeting platform beginning at 9:45 a.m. Eastern Time on June 2, 2021. We recommend that stockholders log in at that time to ensure they are logged in when the meeting starts.
A replay of the meeting will be available for one year following the meeting date. To listen to a replay of the annual meeting, please visit www.virtualshareholdermeeting.com/ANIP2021 .
About ANI
ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company’s targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products. For more information, please visit our website www.anipharmaceuticals.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210601006001/en/
ANIP Rankings
#367 Ranked by Stock Gains
ANIP Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Other, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Baudette
About ANIP
ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc.
